Invitae (NVTA) Stock Price, News & Analysis

Company Overview

Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

Key Stats

• Today's Range: $0.0003 to $0.0003
• 50-Day Range: N/A
• 52-Week Range: $0.02 to $0.02
• Volume: 75 shs
• Average Volume: 23.72 million shs
• Market Capitalization: $80.10 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NVTA Stock Analysis - Frequently Asked Questions

How were Invitae's earnings last quarter?

Invitae Co. (NYSE:NVTA) released its quarterly earnings data on Tuesday, May, 9th. The medical research company reported ($0.37) earnings per share for the quarter, topping the consensus estimate of ($0.41) by $0.04. The company's revenue was down 5.1% compared to the same quarter last year.

When did Invitae IPO?

Invitae (NVTA) raised $76 million in an initial public offering (IPO) on Thursday, February 12th 2015. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan served as the underwriter for the IPO and Cowen and Company and Leerink Partners were co-managers.

What other stocks do shareholders of Invitae own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Invitae investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), CrowdStrike (CRWD), Teladoc Health (TDOC) and PayPal (PYPL).

Company Calendar

• Last Earnings: 5/09/2023
• Today: 7/02/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical laboratories
• Sub-Industry: N/A
• Current Symbol: NYSE:NVTA
• CIK: 1501134
• Web: www.invitae.com
• Phone: (628) 213-3369
• Fax: N/A
• Employees: 1,700
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($5.38)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$3.11 billion
• Net Margins: -299.14%
• Pretax Margin: -301.93%
• Return on Equity: -6,100.71%
• Return on Assets: -19.68%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.39
• Quick Ratio: 2.25

Sales & Book Value

• Annual Sales: $481.58 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.42 per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 267,010,000
• Free Float: 284,373,000
• Market Cap: $80.10 thousand
• Optionable: Optionable
• Beta: 1.59